We also upped our CASH POSITION to 75-MILLION DOLLARS, enough to run for the next 3-years.
Seems that they sold a couple of million shares during the take off. if so, nice to have more money with less dilution than earlier occasions. Talk of more bucks for the bang.
So much GOOD NEWS in this PR. Also stated we have a supply for 1-year commercialization for Rett Syndrome!!
Seems that they are confident of getting approval.
Are they currently talking to the FDA about Rett; if yes, what is the feedback from FDA(question to ask during CC time)
We are on track with 3-71 as well. The conference call hopefully will throw more light on the matter. WE GOT THIS!!!!!!!!!!!!!!!!!!
Getting started with 3-71 is good for now. Probably will pick pace once Rett is in the bag and we have additional money to spare (possibility of that voucher).
Conference Call - for a change we need some good questions.
News 
Market Data 
Discover 
